Skip to main content
Depression- A Mood Disorder
Mood Disorders are interrelated sets of psychiatric symptoms
characterized by a core deficit in emotional self-regulations.
1. Depressive Disorders
-Dysphoric [Low Mood]
2. Bipolar Disorders
-Dysphoric Euphoric [High Mood]
DEPRESSION-TYPES (DSM-5)
• MAJOR
DEPRESSIVE
DISOREDERS
• PERSISTENT
DEPRESSIVE
DISORDER
• DISRUPTIVE
MOOD
DYSREGULATION
DISORDER
• OTHER
SPEICIFIED/
UNSPECIFIED
DEPRESSIVE
DISORDER
• PREMENSTRUAL
DYSPHORIC
DISORDER
• SUBSTANCE/
MEDICATION
INDUCED
DISORDERS
MAJOR DEPRESSIVE DISORDER
• DSM-5 CRITERIA:
5 OR MORE SYMPTOMS
+
AT LEAST 2WEEKS DURATION
+
CHANGE FROM PREVIOUS FUNCTIONING
SYMPTOM THAT MUST BE PRESENT- ( at least 1)
1. DEPRESSED MOOD
OR
2. LOSS OF INTEREST OR PLEASURE
MAJOR DEPRESSIVE
DISORDER contd.
SymptomsList
Vegetative symptoms-
1. Disturbed appetite
2. Disturbed sleep
3. Disturbed energy level
4. Disturbed Activity level
Cognitive Symptoms-
1. Impaired concentration
2. Thoughts of Worthlessness or
excessive & inappropriate guilt
feeling, Feeling of Helplessness
and Hopelessness (COGNITIVE
TRIAD)
3. Suicidal thoughts or actions
MAJOR DEPRESSIVE DISORDER contd.
• Types:
Mild- Few or no, symptoms in excess of those required to make the
diagnosis. Mildly distressing, manageable, mild functional
impairment.
Severe- Symptoms substantially in excess of those required to make
the diagnosis. Highly distressing, unmanageable, markedly impair
function.
Moderate- intermediate severity.
PERSISTENT DEPRESSIVE DISORDER
(DYSTHYMIA)
• Depressed or Irritable mood for at least 1 year (for children and
adolescents).
• Chronic form of depression having vegetative and cognitive
symptoms.
• Cognitive symptoms are less severe. Eg., low self esteem rather than
worthlessness; hopelessness rather than suicidality.
• Types- Mild, Moderate, Severe ( Same as MDD)
PERSISTENT DEPRESSIVE
DISORDER (DYSTHYMIA)
contd.
MDD and Dysthymia
• Overall clinical presentations in children and adolescents are same as
adult.
• Prominence of symptoms can change with age-
 Irritability and somatic complaints more common in children
 Energy, activity level, appetite and sleep disturbances more
common in adolescents
DISRUPTIVE MOOD DYSREGULATION
DISORDER (DMDD)
• Severe, Persistent IRRITABILITY FOR at least 12 months in multiple
settings- at HOME, at SCHOOL, with PEERS.
• Frequent and Severe temper outburst- verbal &/or physical
• Persistently irritable and angry mood for most of the day, nearly
everyday
NB- Oppositional Defiant Disorder (ODD) and intermittent Explosive
Disorder (IED) have some similar characteristics but in milder form.-
Both diagnosis cannot coexist with DMDD.
Conventional Hierarchical Diagnostic Rules apply for
DMDD,BPD,ODD,IED- as symptoms overlap.
BPD>DMDD>ODD & IED
DISRUPTIVE MOOD DYSREGULATION
DISORDER (DMDD) contd.
DSM-5 CRITERIA FOR DMDD
OTHER SPECIFIED/UNSPECIFIED DEPRESSIVE
DISORDER
• Sub-syndromal depressive disorder
• Symptoms characteristic of depressive disorder and cause clinically
significant distress or functional impairment.
• Do not meet the full criteria for any of the disorders in this diagnostic
class.
EPIDEMIOLOGY
• The overall prevalence rates of childhood depression in India vary
anywhere between 0.3% to about 1.2%. The NMHS (2015-16)
reported a prevalence rate of 0.8% (CI 0.3–1.4) for depression among
13–17 year-old children. (WHO 2017)
• Male : Female ratio approximates 1:1 in childhood; early adolescence
rises to 1:1.5-3.0.
CLINICAL COURSE
• May first appear at any age but likelihood of onset increase markedly with
Puberty.
• Course is quite variable- some rarely or never experience remission, others
experience many years with few or no symptoms between episodes.
• Dysthymia has often early and insidious onset.
• Prepubertal age group exhibit more heterotypic than homotypic continuity
(Mostly in adult), ie. Depressed children develop nondepressive psychiatric
disorder in their adulthood.
• Adolescents has Homotypic continuity, recurrence probability 50%-70%.
• Severe symptoms, longer time to remission, maltreatment, comorbid
psychiatric disorder- NEGATIVE PROGNOSTIC FACTORS.
• 20% of depressed adolescents develop BPD.
DIFFERENTIAL DIAGNOSIS
• MEDICAL CONDITIONS-
Neurologic disorders
Endocrine disorders
Infectious Diseases
Tumors
Anemia
Uremia
Failure to thrive
Chronic fatigue disorder
Pain disorder
• MEDICATIONS-
Narcotics
Chemotherapy
Beta Blockers
Corticosteroids
Contraceptives
PSYCHIATRIC CONDITIONS-
Autism Spectrum Disorder
ADHD
Bipolar Disorders
Anxiety Disorders
Trauma and Stressor related
Disruptive/Impulse
control/Conduct disorder
Substance related disorders
COMORBIDITY
• 40%-90% Youth with Depressive disorders have other psychiatric
disorders, and up to 50% have 2 or more comorbid diagnosis.
• Most common comorbidity- ANXIETY DISORDER
• Other common comorbidities- ADHD, DISRUPTIVE BEHAVIOUR, EATING
& SUBSTANCE USE.
• DMDD can be co-occurred with other depressive disorder, ADHD,
Conduct disorder, substance use
SEQUELAE
• 60% Youth with MDD report thinking about suicide and 30 % actually
attempt.
• Risk of Suicide increases if- history of attempts, exposure to adverse
psychosocial circumstances, family history of suicidal behaviour,
comorbid psychiatric disorders.
• High risk of- Substance abuse, Impaired family and Peer relationship,
Early Pregnancy, Legal problem, Educational and Occupational
achievement, Poor adjustment to life stressors.
• Children with DMDD have displayed elevated rate of Social
impairment, School suspension, Service use.
ETIOLOGY AND RISK FACTORS
• Vulnerability grounded in gene by environmental pathways.
• 2-4 fold bidirectional increase among 1st degree relatives & 40-65%
concordance in monozygotic twins.
• Biologic Risk Factors-
Cerebral variation in structure
& function ( particularly
serotonergic)
Variation in HPA axis function
Difficult
temperament/personality
(negative affectivity)
Ruminative, Self-devaluating
cognitive style
• Psychosocial factors-
Physical/sexual abuse
Neglect
Chronic illness
School difficulties (bullying, academic failure)
Social isolation
Family/Marital disharmony
Divorce/Separation
Parental psychopathology
Domestic violence
PROTECTIVE FACTORS AND PREVENTION
• Protective Factors-
Positive Relationship with a
parent
Better family function
Closer parental
supervision/monitoring/
involvement
Prosocial peer group
Higher IQ
Greater educational
aspirations
• Prevention-
Psychosocial and Educational
strategies
Various programs to provide
information about the Link
Between Depressed Mood and
Depressogenic thoughts and
Behaviour and training in skills
intended to modify these thoughts
and behaviour
SCREENING/CASE FINDING
• Targeted Screening Strategy-
Known High Risk Groups: Homeless, Refugees, Involved with child welfare or
Juvenile Justice
Youth experiencing known psychosocial adversities
Self reporting a dysphoric mood
• Various Standardized Screening Tools-
Broadband: 1. Paediatric Symptom Checklist 2. Strengths and Difficulties
Questionnaire 3. Vanderbilt ADHD Diagnostic Rating Scale
Narrowband: 1. Beck Depression Inventory 2. Patient Health Questionnaire-9
DETECTION OF DEPRESSION IN ADOLESCENTS
IN NONSPECIALIST SETTINGS
MANAGEMENT
• Stepped Approach- by Active Case Finding & Initial Management.
• High rates of response to Placebo and Attention Comparators.
EARLY INTERVENTION
Paediatric practitioner assesses Onset, Duration, Context & Severity of Symptoms
If acute dangerousness (E.g. Suicidality, psychosis, substance abuse) and significant distress/ functional
impairment ABSENT
Follow up in 1-2wks to conduct depression assessment using a depression screening instrument
If Mild Symptoms- GUIDED SELF-HELP (Anticipatory Guidance) with watchful waiting
Additional follow up visits to follow the progress
If continued mild symptoms- Supportive Psychotherapy- individual or group format focusing on Teaching
Thoughts (E.g. Positive self talk) and Behaviour ( Pleasurable activities, relaxation, problem solving, effective
communication)
MANAGEMENT Contd.
• Not responding to 4-6
wk of Supportive
Psychotherapy
• Moderate to Severe,
Comorbid or Recurrent
Depression
• Suicidality
• History of Mania,
Traumatic Exposure
Severe Family
Dysfunction
• Psychopathology
Assessment and
Treatment in the
specialty Mental
Health Setting by a
Child-trained
Mental Health
Clinician
MANAGEMENT Contd.
• Moderate to Severe Depression
Specific Manualized Psychotherapies
Antidepressant Medication
Combination of the two
• Goal of acute treatment phase-
Achieve Response, i.e., at least
50% reduction in depressive
symptoms as assessed by a
Standardized Rating Scale
• Ultimate Treatment Goal- Full
Recovery, i.e., Absence of a
Depressive diagnosis.
MANAGEMENT Contd.
Specific Manualized Psychotherapies
Cognitive Behavioural Therapy
(CBT)
 Identifying & Correcting
Cognitive Distortions
 Teaches problem solving
 Behaviour Activation
 Social Communication
 Emotional regulation skills
Interpersonal
Therapy
decrease
interpersonal
conflicts
 Enhancing
Interpersonal
Problem Solving
 Social
Communication
Each of these involves approximately 8-12
weekly visits
Family Therapy
Though little evidence is available
regarding it’s effectiveness, some suggest
that it’s better than NO THERAPY
MANAGEMENT Contd.
ANTIDEPRESSANT MEDICATIONS
2 Selective Serotonin Reuptake Inhibitor (SSRI) is approved for
Depression as 1st line agent- 1. FLUOXETINE (greater efficacy) 2.
ESCITALOPRAM.
In preadolescents only FLUOXETINE is approved.
If there are comorbidities, side effect to 1st line agents, personal or
family history of response to specific medication- alternate options
are- 1. SERTRALINE 2. CITALOPRAM.
60% of patients respond, 30% among them experience symptom
remission.
MANAGEMENT Contd.
Side-effects: 1. MC- Irritability, GI disturbances, Sleep disturbances, Dizziness,
Change in appetite, Dry mouth.
2. Behavioural activation- particularly in children- Increased Impulsivity,
Agitation, Irritability.
3. Serotonin Toxicity- Bleeding, Arrhythmia (Citalopram causing dose-
dependent QT prolongation), increased suicidal thoughts.
Initial dose is approximately half of adult dose (e.g., 10mg of Fluoxetine)
Treatment should be continued for 6-12months- as there is high rate of recurrence
All antidepressants should be discontinued gradually to avoid WITHDRAWAL
SYMPTOMS ( GI upset, Disequilibrium, Sleep disruption, Flu-like symptoms, Sensory
disturbances)
MANAGEMENT Contd.
Depression in children and adolescents